David Fenstermaker Ph D is categorized under Outpatient Drug Clinics in Olympia, WA and active since 2010.
David Fenstermaker Ph D was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Outpatient Drug Clinics business, which does work in the B2C market, and is classified as a Outpatient Drug Clinics, under code number 621498 by the NAICS.
If you are seeking more information, feel free to contact David Fenstermaker at the company’s single location by writing to 2010 Seaton Court Se, Olympia, Washington WA 98513 or by phoning (360) 438-8626. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | David Fenstermaker Ph D |
| Contact Person: | David Fenstermaker |
| Address: | 2010 Seaton Court Se, Olympia, Washington 98513 |
| Phone Number: | (360) 438-8626 |
| Website Address: | davidfenstermaker.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Outpatient Drug Clinics |
| SIC Code: | 8093 |
| NAICS Code: | 621498 |
| Share This Business: |
David Fenstermaker Ph D was started in 2010 to provide professional Outpatient Drug Clinics under the SIC code 8093 and NAICS code 621498. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact David Fenstermaker for inquiries that concern David Fenstermaker Ph D by calling the company number (360) 438-8626, as your correspondence is most welcome. Additionally, the physical location of the single location of David Fenstermaker Ph D can be found at the coordinates 47.031846,-122.739095 as well as the street address 2010 Seaton Court Se in Olympia, Washington 98513.
For its online presence, you may visit David Fenstermaker Ph D’s website at davidfenstermaker.com and engage with its social media outlets through on Twitter and on Facebook.